Cargando…
Therapeutic disruption of RAD52–ssDNA complexation via novel drug-like inhibitors
RAD52 protein is a coveted target for anticancer drug discovery. Similar to poly-ADP-ribose polymerase (PARP) inhibitors, pharmacological inhibition of RAD52 is synthetically lethal with defects in genome caretakers BRCA1 and BRCA2 (∼25% of breast and ovarian cancers). Emerging structure activity re...
Autores principales: | Bhat, Divya S, Malacaria, Eva, Biagi, Ludovica Di, Razzaghi, Mortezaali, Honda, Masayoshi, Hobbs, Kathryn F, Hengel, Sarah R, Pichierri, Pietro, Spies, M Ashley, Spies, Maria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10150327/ https://www.ncbi.nlm.nih.gov/pubmed/37139244 http://dx.doi.org/10.1093/narcan/zcad018 |
Ejemplares similares
-
High replication stress and limited Rad51-mediated DNA repair capacity, but not oxidative stress, underlie oligodendrocyte precursor cell radiosensitivity
por: Berger, N Daniel, et al.
Publicado: (2022) -
Human Rad52 binds and wraps single-stranded DNA and mediates annealing via two hRad52–ssDNA complexes
por: Grimme, Jill M., et al.
Publicado: (2010) -
Intrinsic ATR signaling shapes DNA end resection and suppresses toxic DNA-PKcs signaling
por: Dibitetto, Diego, et al.
Publicado: (2020) -
Clinical and functional characterization of CXCR1/CXCR2 biology in the relapse and radiotherapy resistance of primary PTEN-deficient prostate carcinoma
por: Armstrong, Chris W D, et al.
Publicado: (2020) -
Proteome dynamics analysis identifies functional roles of SDE2 and hypoxia in DNA damage response in prostate cancer cells
por: Luo, Ang, et al.
Publicado: (2020)